-
Je něco špatně v tomto záznamu ?
Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing
P. Pokorna, G. Lakka Klement, A. Vasikova, V. Kanderova, M. Jezova, K. Noskova, P. Mudry, M. Kyr, T. Merta, V. Bajciova, Z. Krenova, H. Palova, D. Valik, L. Zdrazilova Dubska, O. Slaby, J. Sterba
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
PubMed
35700412
DOI
10.1200/po.21.00525
Knihovny.cz E-zdroje
- MeSH
- aminopyridiny MeSH
- anaplastický velkobuněčný lymfom * farmakoterapie MeSH
- laktamy MeSH
- lidé MeSH
- makrocyklické laktamy MeSH
- pyrazoly terapeutické užití MeSH
- reziduální nádor MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
Central European Institute of Technology Masaryk University Brno Czech Republic
Clinical Pharmacy Section of Hospital Pharmacy University Hospital Brno Brno Czech Republic
CSTS Health Care Toronto ON Canada
Department of Biology Faculty of Medicine Masaryk University Brno Czech Republic
Department of Laboratory Methods Faculty of Medicine Masaryk University Brno Czech Republic
Department of Pharmacology Faculty of Medicine Masaryk University Brno Czech Republic
International Clinical Research Center St Anne's University Hospital Brno Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018219
- 003
- CZ-PrNML
- 005
- 20220804134630.0
- 007
- ta
- 008
- 220720s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1200/PO.21.00525 $2 doi
- 035 __
- $a (PubMed)35700412
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Pokorna, Petra $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic $1 https://orcid.org/000000031037878X
- 245 10
- $a Minimal Residual Disease-Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing / $c P. Pokorna, G. Lakka Klement, A. Vasikova, V. Kanderova, M. Jezova, K. Noskova, P. Mudry, M. Kyr, T. Merta, V. Bajciova, Z. Krenova, H. Palova, D. Valik, L. Zdrazilova Dubska, O. Slaby, J. Sterba
- 650 _2
- $a aminopyridiny $7 D000631
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a laktamy $7 D007769
- 650 _2
- $a makrocyklické laktamy $7 D047029
- 650 12
- $a anaplastický velkobuněčný lymfom $x farmakoterapie $7 D017728
- 650 _2
- $a reziduální nádor $7 D018365
- 650 _2
- $a pyrazoly $x terapeutické užití $7 D011720
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Lakka Klement, Giannoula $u Department of Pediatric Oncology, University Hospital Brno, and Faculty of Medicine, Masaryk University, Brno, Czech Republic $u CSTS Health Care, Toronto, ON, Canada $1 https://orcid.org/0000000274792798
- 700 1_
- $a Vasikova, Alzbeta $u Department of Internal Medicine-Hematology and Oncology, University Hospital Brno, and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Kanderova, Veronika $u CLIP, Department of Pediatric Hematology/Oncology, 2nd Faculty of Medicine, Charles University and University Hospital Motol, Prague, Czech Republic
- 700 1_
- $a Jezova, Marta $u Department of Pathology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Noskova, Kristyna $u Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $u Clinical Pharmacy Section of Hospital Pharmacy, University Hospital Brno, Brno, Czech Republic $1 https://orcid.org/0000000189558438
- 700 1_
- $a Mudry, Peter $u Department of Pediatric Oncology, University Hospital Brno, and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Kyr, Michal $u Department of Pediatric Oncology, University Hospital Brno, and Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000166238386
- 700 1_
- $a Merta, Tomas $u Department of Pediatric Oncology, University Hospital Brno, and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Bajciova, Viera $u Department of Pediatric Oncology, University Hospital Brno, and Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000260123569
- 700 1_
- $a Krenova, Zdenka $u Department of Pediatric Oncology, University Hospital Brno, and Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Palova, Hana $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Valik, Dalibor $u Department of Laboratory Methods, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/000000030922592X
- 700 1_
- $a Zdrazilova Dubska, Lenka $u Department of Clinical Microbiology and Immunology, University Hospital Brno, and Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000163970993 $7 xx0080373
- 700 1_
- $a Slaby, Ondrej $u Central European Institute of Technology, Masaryk University, Brno, Czech Republic $u Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
- 700 1_
- $a Sterba, Jaroslav $u Department of Pediatric Oncology, University Hospital Brno, and Faculty of Medicine, Masaryk University, Brno, Czech Republic $u International Clinical Research Center, St Anne's University Hospital, Brno, Czech Republic $1 https://orcid.org/0000000284828352
- 773 0_
- $w MED00204957 $t JCO precision oncology $x 2473-4284 $g Roč. 6, č. - (2022), s. e2100525
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35700412 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134624 $b ABA008
- 999 __
- $a ok $b bmc $g 1822018 $s 1169462
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 6 $c - $d e2100525 $e - $i 2473-4284 $m JCO precision oncology $n JCO Precis Oncol $x MED00204957
- LZP __
- $a Pubmed-20220720